Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 5959 Results
October 01, 2026
Lazard Advised Fresenius on its Acquisition of the Remaining 45% of mAbxience, Completing Full Ownership of a Vertically Integrated Biosimilars Platform, Valuing the Company at up to €1.67 Billion
$851 Million
September 30, 2026
Deret selects GEODIS to accelerate its growth and create a major French player in contract logistics
Undisclosed
September 28, 2026
Euroports Group Announces Agreement for A.P. Moller Capital to Acquire a Majority Stake
Undisclosed
September 23, 2026
Zymeworks to Acquire Theravance Biopharma
$929 Million
September 23, 2026
Theravance Sells Its Remaining Royalty Interest in Trelegy Ellipta to GSK
$225 Million
September 22, 2026
Sun Communities, Inc. Announces Agreement To Sell UK Assets For Approximately $1.03 Billion In An All-Cash Transaction
$1 Billion
September 21, 2026
Carlyle and Investindustrial Portfolio Company Flos B&B Italia Group Sells Iconic Lighting Brand Louis Poulsen to Chr. Augustinus Fabrikker
Undisclosed
September 21, 2026
Podium Entertainment Acquired by Flexpoint Ford and Shamrock Capital
Undisclosed
September 17, 2026
Carlyle and CVC DIF agree to acquire BauWatch from Haniel
Undisclosed
September 16, 2026